SWITCHED ONcology is a global faculty of experts working together to improve the way cancer care is delivered around the world. With an extensive breadth of oncology experience, and a reputable ...

Pearlcatchers was set up in 2002 to offer a fresh approach to learning, development, teambuilding and events. Having experienced training, change and teambuilding events both internally and through ...

We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we ...

Keytruda (pembrolizumab) and Astellas/Pfizer’s Padcev (enfortumab vedotin) have been approved by the Medicines and Healthcare ...

Eli Lilly has partnered with insitro to advance new treatments for metabolic diseases, including metabolic ...

Roche’s PI3K inhibitor Itovebi (inavolisib) has been approved by the US Food and Drug Administration (FDA) as part of a ...

See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and ...

Merck & Co – known as MSD outside the US and Canada – has entered into a licence and research collaboration agreement worth ...

Merck & Co – known as MSD outside the US and Canada – has shared positive results from a late-stage study of its anti-PD-1 therapy in head and neck cancer. The phase 3 KEYNOTE-689 trial has been ...

Researchers from the Institute of Cancer Research (ICR) have highlighted the potential benefits of treating bladder cancer with personalised radiotherapy. More than 130,000 patients are treated on the ...